Egypt's healthcare claims management market is projected to grow from $74.76 Mn in 2022 to $442.76 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022-30. The main factors driving the growth would be rising health insurance coverage, increasing patient awareness and expectations, government initiatives, and growing demand for digital healthcare technology. The market is segmented by component, type, delivery mode, and by end-user. Some of the major players include MedMisr, Marsh, Cigna, Allianz and Accenture.
Canada Antibacterial (Antibiotics) Drugs Market is at around $4.07 Bn in 2023 and is projected to reach $5.4 Bn in 2030, exhibiting a CAGR of 4.2% during the forecast period. The market is being driven by factors such as the rise in infectious disease incidence, the expansion of healthcare infrastructure, and the increase in awareness and education. The market is dominated by key players like Pfizer Canada, GlaxoSmithKline (GSK), Johnson & Johnson Inc. (J&J), Merck Canada, Abbott Laboratories Limited, Astra Zeneca Canada, Sanofi Canada, Novartis Pharmaceuticals Canada Inc., Eli Lilly Canada Inc., and F. Hoffmann-La Roche Ltd.
This report presents a strategic analysis of the Tanzania Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Tanzania Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Thailand Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Dialysis Market, offering unmatched value, accuracy and expert insights.
The UAE dental care market size is at around $179 Mn in 2022 and is projected to reach $318 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period from 2022 to 2030. The market is growing as the new medical tourism destination for dental care services and is dominated by players like American Dental Clinic, Dr. Sulaiman Al Habib Medical Group, Aster DM Healthcare, and Medcare Hospitals & Medical Centers.
The UK Alopecia (Hair Loss) Therapeutics Market was valued at US $213 Mn in 2022, and is predicted to grow at (CAGR) of 5.5% from 2023 to 2030, to US $327 Mn by 2030. The key drivers of this industry include the surge in the prevalence of Alopecia (hair loss), increased disposable income, technological advancements, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Cipla, Sun Pharmaceuticals, Allergan, and Pfizer, among others.
UK intravenous solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of malnutrition, the quicker turnaround and higher efficacy associated with intravenous solution therapy, and the rise in the geriatric population all contribute to the growth of the intravenous solutions market. The key players in this market are Fresenius Kabi AG, Pfizer, Inc., Otsuka Pharmaceutical Co., Ltd., Baxter, B. Braun Melsungen AG, Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, ICU Medical Inc., Grifols, S.A.
Vietnam's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.03 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by the improvement in regulatory frameworks and collaboration between government, industry, and academia. The market is segmented by healthcare components & by healthcare applications. Some of the major players include GE Healthcare, IBM Watson Health & VinBrain.
This report presents a strategic analysis of the Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market, offering unmatched value, accuracy and expert insights.
Telemedicine is a sector of immense growth potential with a market size of about $730 Mn in 2022 with a CAGR of about 19.7% and is expected to grow to $3,075 Mn in 2030 as predicted by Insights10 report on the Australia Telemedicine Market Analysis. The inclusion of telemedicine services by general practitioners and telemedicine coverage in Medicare Australia are major growth drivers. The market is segmented by component, modality, application, and end user. Doxy.me Inc. and Teladoc Health are major market players in telemedicine.
By 2030, it is anticipated that the Australia dermatology drugs market will reach a value of $516 Mn from $204 Mn in 2022, growing at a CAGR of 12.3% during 2022-2030. The market is primarily dominated by local players such as Faulding, Bioscience International, Aspen Pharmacare, and Alpha pharm. The market is driven by an aging population, disparities in universal health coverage, and the launch of new and innovative drugs. This market is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Australia's Electronic Health Record market size was valued at $339 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.5% from 2022-30 and will reach $521 Mn in 2030. Australia's EHR market growth will grow as EHRs give doctors access to more thorough patient data, empowering them to swiftly decide on the best course of treatment, enhance patient care, and reduce safety risks. The key market players are Medical Director, Zedmed, Genie Solutions, Allscripts, Cerner, Epic Systems, and others.